Stock message boards
MNV
Market News Video
MNV MNV The 10 Most Popular Large-Caps in ETFs
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Interesting August Stock Options for JPM
Monday, June 16, 12:23 PM ET, by Market News Video Staff

Consistently, one of the more popular stocks people enter into their stock options watchlist at ...

Noteworthy ETF Inflows: XLF, WFC, BRK.B, JPM
Friday, June 20, 11:06 AM ET, by Market News Video Staff

Symbols mentioned in this story: XLF, WFC, BRK.B, JPM Exchange traded funds (ETFs) trade just ...

Interesting October Stock Options for JPM
Monday, June 23, 12:18 PM ET, by Market News Video Staff

Consistently, one of the more popular stocks people enter into their stock options watchlist at ...

Interesting LF Put Options For August 16th
Tuesday, June 24, 11:16 AM ET, by Market News Video Staff

Investors in Leapfrog Enterprises Inc (LF) saw new options begin trading this week, for the ...

JPMorgan Chase Becomes #21 Most Shorted Dow Stock, Replacing American Express
Wednesday, June 25, 9:17 AM ET, by Market News Video Staff

The most recent short interest data has been released by the NASDAQ for the 06/13/2014 ...

  More articles:  1 2 3 4 5 6 7 next »

Today's Big Losers: LF, THOR

By Market News Video Staff, Wednesday, January 12, 3:26 PM ET
Play Video: The Importance of ETFs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Educational toy maker LeapFrog Enterprises (NYSE:LF) lowered its full-year earnings forecast due to reduced demand for its toys during the holidays.

The company forecast both sales and earnings below estimates. The company now forecasts sales to increase 13-14 percent for the full year, or $433 million, below estimates of $452.3 million and growth of 15-20 percent. Full-year earnings are forecast to be 3-6 cents a share, below analyst expectations of 28 cents a share.

The stock is trading lower by over 22.5 percent.

Thoratec (NASDAQ:THOR) shares are lower on Wednesday after following a lackluster presentation at the JP Morgan (NYSE:JPM) Healthcare Conference. Following the conference, JP Morgan reiterated its "neutral" rating on the stock, and gave it a $30 price target.

Shares are lower by over 6.8 percent.


Top Six Most Viewed Stories This Week @ Market News Video:
S&P 500 Movers: PEG, PETMS&P 500 Movers: PEG, PETM
Channel: Large Cap Stocks
Related symbols: PEG,PETM
S&P 500 Movers: GNW, LOS&P 500 Movers: GNW, LO
Channel: Large Cap Stocks
Related symbols: GNW,LO
S&P 500 Movers: DAL, STZS&P 500 Movers: DAL, STZ
Channel: Large Cap Stocks
Related symbols: DAL,STZ
S&P 500 Movers: TSCO, NEMS&P 500 Movers: TSCO, NEM
Channel: Large Cap Stocks
Related symbols: TSCO,NEM
S&P 500 Movers: URBN, NFLXS&P 500 Movers: URBN, NFLX
Channel: Large Cap Stocks
Related symbols: URBN,NFLX
S&P 500 Analyst Moves: NUS&P 500 Analyst Moves: NU
Channel: Upgrades/Downgrades
Related symbols: NU

This Article's Word Cloud:   Conference   Definition   Earnings   Following   Full   Healthcare   LeapFrog   Market   Morgan   NYSE   Nasdaq   Share   Shares   THOR   Thoratec   Wednesday   after   below   both   cents   company   conference   demand   during   earnings   estimates   expectations   forecast   full   growth   holidays   increase   lower   lowered   maker   million   neutral   over   percent   price   rating   reduced   sales   share   shares   stock   target   toys   trading   year
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
MNV
Home  |  Analyst News  Dividend Report  Econonomic News  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Message Boards Stock Market Definitions
MNV

Today's Big Losers: LF, THOR | Market News Video | Copyright © 2008 - 2014, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.